In Vivo Volume and Hemoglobin Dynamics of Human Red Blood Cells

Human red blood cells (RBCs) lose ~30% of their volume and ~20% of their hemoglobin (Hb) content during their ~100-day lifespan in the bloodstream. These observations are well-documented, but the mechanisms for these volume and hemoglobin loss events are not clear. RBCs shed hemoglobin-containing ve...

Full description

Bibliographic Details
Main Authors: Malka, Roy, Higgins, John M., Manalis, Scott R, Delgado, Francisco Feijo
Other Authors: Massachusetts Institute of Technology. Department of Biological Engineering
Format: Article
Language:en_US
Published: Public Library of Science 2014
Online Access:http://hdl.handle.net/1721.1/90976
https://orcid.org/0000-0001-5223-9433
_version_ 1826190353885036544
author Malka, Roy
Higgins, John M.
Manalis, Scott R
Delgado, Francisco Feijo
author2 Massachusetts Institute of Technology. Department of Biological Engineering
author_facet Massachusetts Institute of Technology. Department of Biological Engineering
Malka, Roy
Higgins, John M.
Manalis, Scott R
Delgado, Francisco Feijo
author_sort Malka, Roy
collection MIT
description Human red blood cells (RBCs) lose ~30% of their volume and ~20% of their hemoglobin (Hb) content during their ~100-day lifespan in the bloodstream. These observations are well-documented, but the mechanisms for these volume and hemoglobin loss events are not clear. RBCs shed hemoglobin-containing vesicles during their life in the circulation, and this process is thought to dominate the changes in the RBC physical characteristics occurring during maturation. We combine theory with single-cell measurements to investigate the impact of vesiculation on the reduction in volume, Hb mass, and membrane. We show that vesicle shedding alone is sufficient to explain membrane losses but not volume or Hb losses. We use dry mass measurements of human RBCs to validate the models and to propose that additional unknown mechanisms control volume and Hb reduction and are responsible for ~90% of the observed reduction. RBC population characteristics are used in the clinic to monitor and diagnose a wide range of conditions including malnutrition, inflammation, and cancer. Quantitative characterization of cellular maturation processes may help in the early detection of clinical conditions where maturation patterns are altered.
first_indexed 2024-09-23T08:39:00Z
format Article
id mit-1721.1/90976
institution Massachusetts Institute of Technology
language en_US
last_indexed 2024-09-23T08:39:00Z
publishDate 2014
publisher Public Library of Science
record_format dspace
spelling mit-1721.1/909762022-09-23T13:32:55Z In Vivo Volume and Hemoglobin Dynamics of Human Red Blood Cells Malka, Roy Higgins, John M. Manalis, Scott R Delgado, Francisco Feijo Massachusetts Institute of Technology. Department of Biological Engineering Koch Institute for Integrative Cancer Research at MIT Feijo Delgado, Francisco Feijo Manalis, Scott R. Human red blood cells (RBCs) lose ~30% of their volume and ~20% of their hemoglobin (Hb) content during their ~100-day lifespan in the bloodstream. These observations are well-documented, but the mechanisms for these volume and hemoglobin loss events are not clear. RBCs shed hemoglobin-containing vesicles during their life in the circulation, and this process is thought to dominate the changes in the RBC physical characteristics occurring during maturation. We combine theory with single-cell measurements to investigate the impact of vesiculation on the reduction in volume, Hb mass, and membrane. We show that vesicle shedding alone is sufficient to explain membrane losses but not volume or Hb losses. We use dry mass measurements of human RBCs to validate the models and to propose that additional unknown mechanisms control volume and Hb reduction and are responsible for ~90% of the observed reduction. RBC population characteristics are used in the clinic to monitor and diagnose a wide range of conditions including malnutrition, inflammation, and cancer. Quantitative characterization of cellular maturation processes may help in the early detection of clinical conditions where maturation patterns are altered. United States. Army Research Office (Institute for Collaborative Biotechnologies Contract W911NF-09-D-0001) National Institutes of Health (U.S.) (Director's New Innovator Award) National Institutes of Health (U.S.) (Grant 1DP2DK098087) 2014-10-20T12:39:11Z 2014-10-20T12:39:11Z 2014-10 2014-05 Article http://purl.org/eprint/type/JournalArticle 1553-7358 1553-734X http://hdl.handle.net/1721.1/90976 Malka, Roy, Francisco Feijo Delgado, Scott R. Manalis, and John M. Higgins. “In Vivo Volume and Hemoglobin Dynamics of Human Red Blood Cells.” Edited by Daniel A. Beard. PLoS Comput Biol 10, no. 10 (October 9, 2014): e1003839. https://orcid.org/0000-0001-5223-9433 en_US http://dx.doi.org/10.1371/journal.pcbi.1003839 PLoS Computational Biology Creative Commons Attribution http://creativecommons.org/licenses/by/4.0/ application/pdf Public Library of Science Public Library of Science
spellingShingle Malka, Roy
Higgins, John M.
Manalis, Scott R
Delgado, Francisco Feijo
In Vivo Volume and Hemoglobin Dynamics of Human Red Blood Cells
title In Vivo Volume and Hemoglobin Dynamics of Human Red Blood Cells
title_full In Vivo Volume and Hemoglobin Dynamics of Human Red Blood Cells
title_fullStr In Vivo Volume and Hemoglobin Dynamics of Human Red Blood Cells
title_full_unstemmed In Vivo Volume and Hemoglobin Dynamics of Human Red Blood Cells
title_short In Vivo Volume and Hemoglobin Dynamics of Human Red Blood Cells
title_sort in vivo volume and hemoglobin dynamics of human red blood cells
url http://hdl.handle.net/1721.1/90976
https://orcid.org/0000-0001-5223-9433
work_keys_str_mv AT malkaroy invivovolumeandhemoglobindynamicsofhumanredbloodcells
AT higginsjohnm invivovolumeandhemoglobindynamicsofhumanredbloodcells
AT manalisscottr invivovolumeandhemoglobindynamicsofhumanredbloodcells
AT delgadofranciscofeijo invivovolumeandhemoglobindynamicsofhumanredbloodcells